127 related articles for article (PubMed ID: 2973933)
21. Treatment of chronic dyskinesia with CDP-choline.
Arranz J; Ganoza C
Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic effects of cyticholine (cytidine-diphospho-choline) in Parkinsonian syndrome].
Ruggieri S; Zamponi A; Casacchia M; Agnoli A
Clin Ter; 1976 Sep; 78(6):515-25. PubMed ID: 797506
[No Abstract] [Full Text] [Related]
23. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
24. [Changes in the carotid atheromatous plaques and in flow conditions in patients with cerebrovascular pathology after treatment with CDP choline. Clinico-instrumental study].
Bellagamba G; Gentili G; Caratelli L; Balestrini F; Fratalocchi N; Assouad C; Moretti V; Dragonetti G; Evangelisti A; Salvolini U
Minerva Cardioangiol; 1984; 32(7-8):483-8. PubMed ID: 6387537
[No Abstract] [Full Text] [Related]
25. Citicoline: pharmacological and clinical review, 2006 update.
Secades JJ; Lorenzo JL
Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
[TBL] [Abstract][Full Text] [Related]
26. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.
Franco-Maside A; Caamaño J; Gómez MJ; Cacabelos R
Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):597-607. PubMed ID: 7760585
[TBL] [Abstract][Full Text] [Related]
27. [Double-blind study on the effect of citicholine on the senile brain].
Bonavita E; Chioma V; Dall'Oca P; Fini C; Michelini M; Ruggi MR; Merli R; Ferro O
Minerva Psichiatr; 1983; 24(2):53-62. PubMed ID: 6656550
[No Abstract] [Full Text] [Related]
28. [Senile dementia and the cholinergic system: a pharmacologic proposal].
Tassi C; Pinca L; Calcaterra FM; Santambrogio S
Minerva Psichiatr; 1983; 24(4):155-8. PubMed ID: 6676621
[No Abstract] [Full Text] [Related]
29. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
Brown ES; Gorman AR; Hynan LS
J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
[TBL] [Abstract][Full Text] [Related]
30. Citicoline improves memory performance in elderly subjects.
Alvarez XA; Laredo M; Corzo D; Fernández-Novoa L; Mouzo R; Perea JE; Daniele D; Cacabelos R
Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):201-10. PubMed ID: 9203170
[TBL] [Abstract][Full Text] [Related]
31. [CDP choline and experimental cerebrovascular disorder].
Le Poncin-Lafitte M; Duterte D; Lageron A; Rapin JR
Agressologie; 1986 May; 27(5):413-6. PubMed ID: 3766895
[No Abstract] [Full Text] [Related]
32. CDP-choline as a drug for pancreatitis.
Hashihira S; Nishii T; Mori R; Takeda Y; Tai J
Bull Osaka Med Sch; 1974 Jul; 20(1):19-25. PubMed ID: 4457204
[No Abstract] [Full Text] [Related]
33. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
Alvarez-Sabín J; Román GC
Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
[TBL] [Abstract][Full Text] [Related]
34. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia.
Di Perri R; Coppola G; Ambrosio LA; Grasso A; Puca FM; Rizzo M
J Int Med Res; 1991; 19(4):330-41. PubMed ID: 1916007
[TBL] [Abstract][Full Text] [Related]
35. [Cytidine diphosphate cholinne -- a new drug in the treatment of spasticity].
Hernando C; De Blas A; Cubells JM
Rev Clin Esp; 1978 Nov; 151(4):313-7. PubMed ID: 741011
[No Abstract] [Full Text] [Related]
36. Citicoline: pharmacological and clinical review, 2010 update.
Secades JJ
Rev Neurol; 2011 Mar; 52 Suppl 2():S1-S62. PubMed ID: 21432836
[TBL] [Abstract][Full Text] [Related]
37. [Is it possible to improve erythrocyte deformability in vascular diseases in the aged? Preliminary study].
Crolle G; Cucca S; Gosparini B; Baso G; Martechini A; Urbani N; Vattolo S
Minerva Med; 1985 Jul; 76(28-29):1349-51. PubMed ID: 3895045
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral CDP-choline on experimental withdrawal syndrome.
Tornos ME; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
[TBL] [Abstract][Full Text] [Related]
39. [Reaction times during citicoline treatment].
Bettini R; Gorini M
Clin Ter; 2002; 153(4):247-50. PubMed ID: 12400212
[TBL] [Abstract][Full Text] [Related]
40. [Clinical flow sonographic and telethermographic evaluation of arteriopathy patients treated with CDP-choline].
Setti M; Ambrosi R; Nespoli M; Terraneo F; Briolini F; Losapio GM
Minerva Cardioangiol; 1985 Dec; 33(12):859-62. PubMed ID: 3912681
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
